Voluntary Information Disclosure Notice on the Proposed Selection of the Tenth Batch of Centralized National Drugs Procurement
Sinopharm Hyundai: Announcement on the holding subsidiary obtaining a drug registration certificate
Announcement on the holding subsidiary obtaining a drug registration certificate
Sinopharm Hyundai: Announcement on the Wholly-owned Subsidiary Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Announcement on the wholly-owned subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Sinopharm Hyundai: Announcement of Resolutions of the 17th (Interim) Meeting of the Eighth Board of Directors
Announcement of Resolutions of the 17th (Interim) Meeting of the Eighth Board of Directors
Sinopharm Hyundai: Announcement on the holding subsidiary obtaining a drug registration certificate
Announcement on the holding subsidiary obtaining a drug registration certificate
Voluntary Information Disclosure Notice on Wholly Owned Subsidiary Drugs Passing the Generic Drug Consistency Evaluation
Announcement on the resignation of the Chief Financial Officer
Announcement on attending the 2024 three-quarter report collective performance briefing for listed companies in Shanghai
Sinopharm Hyundai: Voluntary Information Disclosure Notice on the Company\'s Drugs Passing the Generic Drug Consistency Evaluation
Voluntary Information Disclosure Notice on the Company\'s Drugs Passing the Generic Drug Conformity Assessment
Sinopharm Hyundai: Announcement on Preparation for Accrual Impairment
Sinopharm Hyundai: Announcement of Resolutions of the 16th Meeting of the Eighth Board of Directors
Sinopharm Hyundai: third quarter report 2024
Third Quarter Report 2024
Announcement of Resolutions of the 16th Meeting of the Eighth Board of Directors
Announcement on preparation for depreciation